• Home > Publications
  • Feature ER-a36 could be a target in TAM-resistant breast tumors.
    Application WB
    Species Homo sapiens
    Targets ER-α36
    Catergory Membrane receptor
    Title Estrogen receptor-β36 is involved in development of acquired tamoxifen resistance via regulating the growth status switch in breast cancer cells.
    Publication Jiang Cao, MOL ONCOL, 2013
    Methods The monoclonal ER-a36 antibody was developed by Abmart, Inc. (Shanghai, China)